Related Experiment Video
Updated: Jul 9, 2025

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
Published on: December 21, 2014
Inhibition of Oral Fibrinogenesis Through Transforming Growth Factor-Beta/SMAD2/3 Signalling Inhibition Using
Jency Evanjelin P1, Umamaheswari Tn1, Elumalai Perumal2
1Department of Oral Medicine and Radiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND.
Mangosteen pericarp extract shows promise in treating oral submucous fibrosis (OSF). It effectively reduced cancer-risk cell growth and key fibrosis markers, suggesting a potential natural therapy for this condition.
Area of Science:
- Oral pathology
- Natural product chemistry
- Fibrosis research
Background:
- Areca nut chewing causes oral submucous fibrosis (OSF), a pre-cancerous condition prevalent in Southeast Asia.
- Tobacco use exacerbates malignant transformation risk in OSF patients.
- Mangosteen pericarp extract is investigated for its therapeutic potential.
Purpose of the Study:
- To evaluate the anti-fibrosis effects of mangosteen pericarp extract on OSF.
- To assess its potential in preventing malignant transformation of OSF cells.
Main Methods:
- Ex vivo study on normal and fibrotic buccal mucosal fibroblasts.
- Cytotoxicity, cell proliferation, and migration assays.
- Gene expression analysis of TGF-β/Smad2 pathway, α-SMA, and type I collagen via real-time PCR.
Main Results:
- Mangosteen extract demonstrated higher cytotoxicity towards fibrotic cells than normal cells.
- Downregulation of TGF-β/Smad2 signaling pathway observed.
- Reduced expression of α-SMA and type I collagen in treated cells.
Conclusions:
- Mangosteen pericarp extract exhibits anti-fibrosis properties.
- It shows potential in preventing oral fibrogenesis and halting malignant transformation in OSF.
Related Concept Videos
TGF - β Signaling Pathway
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis

